Interferon alfa-2b therapy in children with chronic hepatitis B
about
A dose ranging study of the pharmacokinetics, safety, and preliminary efficacy of lamivudine in children and adolescents with chronic hepatitis B.Treatment of chronic hepatitis B virus infection in special groups of patients: decompensated cirrhosis, immunosuppressed and paediatric patients.Treatment of viral hepatitis B in children.The pharmacokinetics and safety of adefovir dipivoxil in children and adolescents with chronic hepatitis B virus infection.Safety and efficacy of interferon retreatment in children with chronic hepatitis B.
P2860
Interferon alfa-2b therapy in children with chronic hepatitis B
description
1993 nî lūn-bûn
@nan
1993 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
name
Interferon alfa-2b therapy in children with chronic hepatitis B
@ast
Interferon alfa-2b therapy in children with chronic hepatitis B
@en
Interferon alfa-2b therapy in children with chronic hepatitis B
@nl
type
label
Interferon alfa-2b therapy in children with chronic hepatitis B
@ast
Interferon alfa-2b therapy in children with chronic hepatitis B
@en
Interferon alfa-2b therapy in children with chronic hepatitis B
@nl
prefLabel
Interferon alfa-2b therapy in children with chronic hepatitis B
@ast
Interferon alfa-2b therapy in children with chronic hepatitis B
@en
Interferon alfa-2b therapy in children with chronic hepatitis B
@nl
P2093
P2860
P1433
P1476
Interferon alfa-2b therapy in children with chronic hepatitis B
@en
P2093
P2860
P304
P356
10.1136/GUT.34.2_SUPPL.S87
P407
P433
P577
1993-01-01T00:00:00Z